Outcomes for patients with solid tumors, malignant and non-malignant hematologic disorders, and for recipients of cellular therapy/stem cell transplant continue to improve, through compassionate, multidisciplinary care, and scientific advances. Using molecular diagnostics, we are able to offer targeted treatment for many cancers, and immunotherapy has replaced traditional chemotherapy in many cases. It is the mission … Continue reading Message from Dr. Karen K. Ballen – Division Chief, Hematology and Oncology, December 2020